Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.

29 total trials for this combination

Showing top 10 of 29 trials

Trials

NCT ID	Title	Status	Phase
NCT00781391	Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation	COMPLETED	PHASE3
NCT02164864	Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)	COMPLETED	PHASE3
NCT00403767	An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation	COMPLETED	PHASE3
NCT00412984	Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation	COMPLETED	PHASE3
NCT00808067	RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial	COMPLETED	PHASE3
NCT05643573	A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke	TERMINATED	PHASE3
NCT05757869	A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation	ACTIVE_NOT_RECRUITING	PHASE3
NCT00262600	Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate	COMPLETED	PHASE3
NCT01468701	GLORIA-AF Registry Program - Second and Third Phases	COMPLETED	—
NCT00580216	Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation	TERMINATED	PHASE3

Related Pages

All Atrial fibrillation trials All trials in Daegu, South Korea